Literature DB >> 9180596

Prolongation of the QTc interval in African children treated for falciparum malaria.

L vn Seidlein1, S Jaffar, B Greenwood.   

Abstract

Antimalarial drugs can affect the heart and trigger life-threatening arrhythmias. However, little is known about the frequency with which cardiac abnormalities occur during uncomplicated attacks of malaria. Therefore, we have studied the electrocardiograms of 139 Gambian children with uncomplicated falciparum malaria who were treated with co-artemether, pyrimethamine/sulfadoxine, or chloriquine. The QTc intervals were measured on presentation, and four and eight days after treatment. No significant differences in mean QTc or heart rate were found between children in the three treatment groups on days 0, 4, or 8. After adjustment for the type of antimalarial thearapy in an analysis of variance, the mean (SD) QTc intervals on days 0, 4, and 8 were 402 (22.6), 416 (23.1), and 405 (24.3) msec, respectively. The mean QTc on day 4 was significantly longer than the mean QTc on days 0 or 8 (P < 0.01 in both cases). A quadratic line was fitted for QTc against time for each antimalarial therapy. No significant differences were found between the quadratic lines of the three groups. A weak association was found between QTc and the degree of parasitemia (r = 0.17, P = 0.04) and temperature (r = -0.23, P = 0.01) measured on day 0. The QTcs were measured in 18 children who experienced a second episode of malaria. The changes in QTc observed during second episodes were similar to those observed during the first attack. Changes in QTc in five children who developed severe malaria were similar to those found in the remaining children who did not develop severe malaria. This study indicates that the QTc interval changes during the early phase of malaria and this change is independent of the type of antimalarial therapy given.

Entities:  

Mesh:

Year:  1997        PMID: 9180596     DOI: 10.4269/ajtmh.1997.56.494

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

2.  Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Authors:  F Ezzet; M van Vugt; F Nosten; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose.

Authors:  G O Adjei; B Q Goka; O P Rodrigues; L C G Hoegberg; M Alifrangis; Jal Kurtzhals
Journal:  Ghana Med J       Date:  2009-09

4.  Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.

Authors:  Emma Hughes; Erika Wallender; Richard Kajubi; Prasanna Jagannathan; Teddy Ochieng; Abel Kakuru; Moses R Kamya; Tamara D Clark; Philip J Rosenthal; Grant Dorsey; Francesca Aweeka; Radojka M Savic
Journal:  Clin Infect Dis       Date:  2022-08-31       Impact factor: 20.999

5.  Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.

Authors:  Harin Karunajeewa; Chiv Lim; Te-Yu Hung; Kenneth F Ilett; Mey Bouth Denis; Doung Socheat; Timothy M E Davis
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

6.  Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.

Authors:  Pere Millat-Martínez; Rhoda Ila; Quique Bassat; Oriol Mitjà; Moses Laman; Leanne Robinson; Harin Karunajeewa; Haina Abel; Kevin Pulai; Sergi Sanz; Laurens Manning; Brioni Moore
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

7.  High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children.

Authors:  Johan Ursing; Lars Rombo; Staffan Eksborg; Lena Larson; Anita Bruvoll; Joel Tarning; Amabelia Rodrigues; Poul-Erik Kofoed
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

8.  Disease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria.

Authors:  Louise Roggelin; Daniel Pelletier; Josephine N Hill; Torsten Feldt; Steffi Hoffmann; Daniel Ansong; Justice Sylverken; Jürgen Burhenne; Johanna Fischer-Herr; Parisa Mehrfar; Christian Thiel; Gerd D Burchard; Samuel B Nguah; Jakob P Cramer
Journal:  Malar J       Date:  2014-06-05       Impact factor: 2.979

Review 9.  Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.

Authors:  Olivier Bouchaud; Patrick Imbert; Jean Etienne Touze; Alex N O Dodoo; Martin Danis; Fabrice Legros
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

10.  QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording.

Authors:  Alessandra Fiorentini; Nicola Petrosillo; Angelo Di Stefano; Stefania Cicalini; Laura Borgognoni; Evangelo Boumis; Luigi Tubani; Pierangelo Chinello
Journal:  BMC Cardiovasc Disord       Date:  2012-12-23       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.